BRCA2 and neoplasm: Two of 16 cases of this rare tumor (12.5%) were shown to have the BRCA2 Portuguese founder mutation, with a 14.3% (2/14) frequency observed when considering only the samples with mutations and those in which all BRCA1/BRCA2 coding regions were analyzed.